Dementia, Vascular Disease, Stroke, Parkinson’s Disease Clinical Trial 20203082

[LCID Study Number: 20203082]

PROTECTED TAVR: Stroke PROTECTion with SEntinel During Transcatheter Aortic Valve Replacement

The purpose of this trial is to demonstrate that use of the Sentinel Cerebral Protection System significantly reduces the risk of peri-procedural stroke (=72 hours) after transcatheter aortic valve replacement (TAVR).

Disease/Condition: Dementia, Vascular Disease, Stroke, Parkinson’s Disease

Department: Cardiology

Location: Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-8607

View NCT ID 04149535 on ClinicalTrials.gov
Protocol #: 20203082
Principal Investigator(s): Suzanne J. Baron
Study Coordinator(s): Jean M. Byrne, BS, RN
Trial Phase: Sponsor Initiated Study Category B Device